Effects of sodium orthovanadate on whole kidney and single nephron function

Microwave extraction of Salvia officinalis essential oil and assessment of its GC-MS identification and protective effects versus vanadium-induced nephrotoxicity in Wistar rats models

In this study, we assess the impact of Salvia officinalis essential oil on renal toxicity induced by vanadium in rats. The animals were exposed to either ammonium metavanadate (5 mg/kg body weight) or the combination of vanadium and S. officinalis essential oil (15 mg EO/kg body weight) for 10 days. Vanadium induced significant renal damage, demonstrated by increased plasma levels of urea and creatinine. A marked increase in lipid peroxidation markers and carbonyl protein levels with a significant decrease in enzymatic antioxidants (SOD), catalase (CAT), and glutathione peroxidase (GPx) was also observed in vanadium-treated rats. Histopathological studies also showed vanadium-induced alterations. Concomitant administration of sage essential oil significantly restored biochemical markers and pathological lesions. This protective effect seems to be due to the richness of this extract in β-caryophyllene, limonene, carvacrol, caryophyllene, borneol and α-pinene, and α-pinene and α-thujene. These rates are determined by GC MS.

Vanadate-Induced Renal cAMP and Malondialdehyde Accumulation Suppresses Alpha 1 Sodium Potassium Adenosine Triphosphatase Protein Levels

It has been demonstrated that vanadate causes nephrotoxicity. Vanadate inhibits renal sodium potassium adenosine triphosphatase (Na, K-ATPase) activity and this is more pronounced in injured renal tissues. Cardiac cyclic adenosine monophosphate (cAMP) is enhanced by vanadate, while increased cAMP suppresses Na, K-ATPase action in renal tubular cells. There are no in vivo data collectively demonstrating the effect of vanadate on renal cAMP levels; on the abundance of the alpha 1 isoform (α₁) of the Na, K-ATPase protein or its cellular localization; or on renal tissue injury. In this study, rats received a normal saline solution or vanadate (5 mg/kg BW) by intraperitoneal injection for 10 days. Levels of vanadium, cAMP, and malondialdehyde (MDA), a marker of lipid peroxidation were measured in renal tissues. Protein abundance and the localization of renal α₁-Na, K-ATPase was determined by Western blot and immunohistochemistry, respectively. Renal tissue injury was examined by histological evaluation and renal function was assessed by blood biochemical parameters. Rats treated with vanadate had markedly increased vanadium levels in their plasma, urine, and renal tissues. Vanadate significantly induced renal cAMP and MDA accumulation, whereas the protein level of α₁-Na, K-ATPase was suppressed. Vanadate caused renal damage, azotemia, hypokalemia, and hypophosphatemia. Fractional excretions of all studied electrolytes were increased with vanadate administration. These in vivo findings demonstrate that vanadate might suppress renal α₁-Na, K-ATPase protein functionally by enhancing cAMP and structurally by augmenting lipid peroxidation.

Vanadate-induced suicidal erythrocyte death

Vanadium, a trace element, as vanadate (VO4(3-)) is known to interfere with a wide variety of enzymes including Ca2+ ATPase and Na+/+ ATPase. VO4(3-) is excreted mainly via the kidney. In renal insufficiency, the impaired VO4(3-) excretion leads to VO4(3-) accumulation in blood.The present study explored the effect of VO4(3-) on eryptosis, the suicidal death of erythrocytes. Eryptosis is characterized by cell shrinkage and phosphatidylserine exposure at the erythrocyte surface. Eryptotic cells are phagocytosed and thus rapidly cleared from circulating blood. Stimulators of eryptosis include an increase of the cytosolic Ca2+ concentration. Erythrocyte Ca2+ activity was estimated from Fluo-3 fluorescence, phosphatidylserine exposure from annexin V-binding, and erythrocyte volume from forward scatter in FACS analysis. Exposure of erythrocytes to VO4(3-) increased cytosolic Ca2+ concentration, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration. In conclusion, VO4(3-) induces eryptosis at least partially through increase of cytosolic Ca2+ concentration, an effect presumably contributing to the development of anemia in chronic renal failure.

Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney

This study investigated the selected parameters of the antioxidant system in liver and kidney after in vivo administration of vanadium and/or chromium in rats. Outbred 2-mo-old albino male Wistar rats received drinking water for 12 wk with either sodium metavanadate (SMV; group II); chromium chloride (Cr; group III); or sodium metavanadate and chromium chloride (SMV-Cr; group IV); and group I (control) received deionized water. Chronic treatment with V alone or in combination with Cr produced a significant increase in kidney relative weight. Further, giving rats V alone also led to a significant elevation in liver relative weight. An increase in hepatic Fe concentration and renal Zn content occurred after treatment with V or Cr, respectively. The rats coadministered V and Cr had significantly higher levels of Fe in liver and Zn in kidneys. Simultaneous administration of these two elements resulted in a significant decrease in renal L-ascorbic acid concentration. V given alone significantly decreased GSH content and GSH/GSSG ratio in liver and kidney as well as increased GSSG concentration in liver, whereas Cr alone produced a significant decrease in GSH content in kidney and GSH/GSSG ratio in both organs. In the SMV-Cr-treated group a significant decrease in renal GSH concentration and GSH/GSSG ratio in both organs occurred. A significant increase in liver GSSG content was also found. The observed significant changes in kidney GSH content and in GSH/GSSG ratio in both rat tissues after Cr might result from the pro-oxidant actions of this metal. Thus, oxidative stress, which is a major pathway for V-induced toxicity, might also be associated with Cr(III)-induced adverse effects in rats.

Effect of age on vanadium nephrotoxicity in rats

The present study was designed to assess potential age dependent differences of vanadium nephrotoxicity in the rat following parenteral administration of vanadate. Young (22 days) and adult (62 days) male Sprague-Dawley rats received i.p. injections of sodium orthovanadate at 10 mg/kg/day for 8 consecutive days. Two additional groups of control rats received i.p. injections of 0.9% saline during the same period. Significant age-differences were found in most of the parameters used as indicators of nephrotoxicity in young and adult rats, with adverse renal effects being more severe with age. Vanadium-induced morphologic changes in the kidney were also more pronounced with age. These findings agree with a higher renal concentration of vanadium in the group of adult rats treated with vanadate than in the vanadate-untreated group. The current results can be of concern if in the future, vanadium compounds can be administered in the treatment of diabetic patients.

Hemodynamic effects of vanadate administration in rats with different levels of sodium intake

The acute hemodynamic effect of an intravenous (IV) bolus of vanadate (10 mumol/kg bwt) followed by an IV infusion at 0.5 mumol/kg min was studied in Wistar rats at three different levels of Na intake: low Na+ (0.5 mEq/24 h), normal Na+ (1.5 mEq/24 h), and high Na+ (15 mEq/24 h). Hemodynamic changes were measured using the radioactive microsphere method. Vanadate decreased cardiac output by 52.0 +/- 6.4% in low Na+ rats, by 41.2 +/- 3.3% in normal Na+, and by 29.2 +/- 3.1% in high Na+ group. Total peripheral resistances increased by 47.1 +/- 26% in high Na+ rats, by 80.1 +/- 6.6% in normal Na+, and by 96.3 +/- 4.5% in low Na+ group. Renal blood flow decreased by 70 +/- 4% in low Na+, 58 +/- 3% in normal Na+, and 39 +/- 3% in high Na+. Cerebral, testicular, and splanchnic blood flow showed smaller changes. These results demonstrate that intravenous vanadate induces marked hemodynamic changes that depend on Na+ intake being more striking when the intake of sodium is reduced.

Inhibitory effects of harvested proximal tubular fluid on Jv and delta cNa during acute saline volume expansion in the rat

The present micropuncture experiments were carried out in male Wistar rats during isotonic saline volume expansion (VE) to explore the relative importance of peritubular physical forces and tubular factors on proximal tubular Na transport. Isotonic volume flux, measured by the shrinking drop technique was reduced from 3.53 +/- 0.09 X 10(-4) . mm3 . mm-2 . s-1 with the artificial fluid to 1.79 +/- 0.1 with harvested autologous proximal tubular fluid (HTF) (49%), but only to 2.77 +/- 0.1 (78% of control) with artificial tubular solution (AS), both during volume expansion. delta cNa was reduced from a control of 18.0 +/- 2.2 mmol . kg-1 -14.5 +/- 2.0 with AS (81%) and 10.0 +/- 2.4 with HTF (56%) during VE. Thus both isotonic volume flux as well as delta cNa were reduced to the same degree by saline VE. These results and those obtained previously with mannitol-saline VE, indicate the presence of a factor in harvested proximal tubular fluid of volume expanded rats which inhibits sodium and water transport independent of peritubular osmolarity.

Greater sensitivity to vanadate of rat renal relative to cardiac (Na+ + K+)-ATPase

Vanadate (VO4(-3] produces a positive inotropic effect in rats and also promotes diuresis as well as natriuresis. Although the mechanism(s) of these effects is uncertain, in the kidney, VO4(-3) may act through inhibition of (Na+ + K+)-ATPase activity, whereas in the heart, other or additional mechanisms are likely. Under the assay conditions used in the present study, microsomal (Na+ + K+)-ATPase activities from rat kidney cortex and medulla were inhibited to a greater extent than was left ventricular (Na+ + K+)-ATPase activity over a range of VO4(-3) concentrations. The apparent dissociation constant for left ventricular (Na+ + K+)-ATPase (10.95 +/- 1.26 X 10(-7)M VO4(-3] was significantly greater than that of (Na+ + K+)-ATPase from the cortex (3.46 +/- 0.96 X 10(-7)M VO4(-3] or the medulla (3.32 +/- 0.7 X 10(-7)M VO4(-3), N = 6, P less than .05) whereas there were no significant differences between the effects of VO4(-3) on (Na+ + K+)-ATPase from the cortex and medulla. The greater inhibition by VO4, of (Na+ + K+)-ATPase from the cortex relative to that of the left ventricle, occurred over a range of Na+ and K+ concentrations, and K+ enhanced the inhibition by VO4(-3) to a greater extent for (Na+ + K+)-ATPase from the cortex than the left ventricle. These results suggest that renal (Na+ + K+)-ATPase is more sensitive than left ventricular (Na+ + K+)-ATPase to inhibition by VO4(-3) and would, therefore, be more likely to be modulated in vivo.

Minireview: physiological and pharmacological properties of vanadium

Vanadium is distributed extensively in nature. It is a trace element and is present in almost all living organisms including man. Even though vanadium was originally recognized for its ability to inhibit membrane Na+-K+-ATPase, various laboratory studies now document that this element has the capacity to affect the activity of various intracellular enzyme systems and may modify their physiological functions. Vanadium may be an essential element for normal development and may play an important role in various homeostatic mechanisms, and thus vanadium deficiency may prove to be an important concern. Abnormalities in biological disposition of vanadium may be involved in the pathogenesis of certain neurological disorders or cardiovascular diseases. While the essentiality of this element for living organisms is yet to be established with certainty, vanadium has become an increasingly important element and is used extensively in various heavy industries such as steel, oil, etc.; thus, the incidence of exposure to toxic levels of vanadium to industrial workers has been an increasing concern for toxicologists. To date, little information is available on the physiological or pharmacological actions of vanadium; hence, it is difficult to reach any definitive conclusion concerning its biological significance, essentiality and its role in pathological states. An attempt has been made in this review to broadly document what is known of various biological actions of vanadium.

Specificity of action of vanadate to the organ of corti

Although vanadate strongly inhibits Na/K-ATPase activity of the stria vascularis in vitro, it initially causes no depression of the ouabain-sensitive endocochlear potential (EP) when perfused perilymphatically or via the vasculature. However, when the perilymph of scala tympani is replaced with artificial media containing 0.1 to 1 mM vanadate, there is a large (about 17 mV) increase in the EP of the second cochlear turn. Further experiments showed that the cochlear microphonics declined during the time in which the EP increased, and that the response of these two potentials to vanadate is greater in the second turn than in the first. Injection of 50 n1 of 1 mM vanadate (in artificial endolymph) into the endolymphatic space of the second turn caused no increase in the EP. These results support the notion that the early effects of vanadate are on the contra-luminal membranes of cells of the organ of Corti rather than on the stria vascularis. By superimposing anoxia or furosemide (i.v.) upon vanadate intoxication, we determined that the initial increase of the compound EP due to vanadate alone was due to a reduction in magnitude of the negative component of the EP. It is argued that of the three prevalent theories concerning the generation of the negative EP, the data tend to support the hypothesis that the intracellular potential of the hair cells gives rise to the negative EP.